全文获取类型
收费全文 | 742篇 |
免费 | 54篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 23篇 |
妇产科学 | 7篇 |
基础医学 | 140篇 |
口腔科学 | 46篇 |
临床医学 | 50篇 |
内科学 | 160篇 |
皮肤病学 | 19篇 |
神经病学 | 35篇 |
特种医学 | 101篇 |
外科学 | 77篇 |
综合类 | 28篇 |
预防医学 | 26篇 |
眼科学 | 7篇 |
药学 | 44篇 |
中国医学 | 1篇 |
肿瘤学 | 46篇 |
出版年
2023年 | 4篇 |
2022年 | 4篇 |
2021年 | 3篇 |
2020年 | 7篇 |
2019年 | 3篇 |
2018年 | 16篇 |
2017年 | 13篇 |
2016年 | 18篇 |
2015年 | 13篇 |
2014年 | 8篇 |
2013年 | 18篇 |
2012年 | 23篇 |
2011年 | 32篇 |
2010年 | 25篇 |
2009年 | 38篇 |
2008年 | 24篇 |
2007年 | 48篇 |
2006年 | 14篇 |
2005年 | 16篇 |
2004年 | 17篇 |
2003年 | 9篇 |
2002年 | 20篇 |
2001年 | 12篇 |
2000年 | 16篇 |
1999年 | 15篇 |
1998年 | 27篇 |
1997年 | 45篇 |
1996年 | 45篇 |
1995年 | 28篇 |
1994年 | 19篇 |
1993年 | 18篇 |
1992年 | 7篇 |
1991年 | 22篇 |
1990年 | 12篇 |
1989年 | 25篇 |
1988年 | 25篇 |
1987年 | 15篇 |
1986年 | 15篇 |
1985年 | 14篇 |
1984年 | 13篇 |
1983年 | 13篇 |
1982年 | 8篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 3篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1975年 | 4篇 |
1969年 | 1篇 |
排序方式: 共有814条查询结果,搜索用时 0 毫秒
171.
Vicario G Celio L Bajetta E Zampino M Longhi A Buzzoni R Botti C Bogni A Bombardieri E Rimassa L Laffranchi A 《Oncology reports》1995,2(1):63-68
Megestrol acetate (MA) is one of the most widely used progestins in the palliation of advanced breast cancer, but its optimal dose level has yet to be defined. Forty-six women with progressive advanced disease were given MA according to a monthly loading-dose-schedule (320 mg/day orally) followed by standard-dose maintenance (160 mg/day). Most of the patients had been heavily pretreated with endocrine and/or chemotherapy; all the cases were evaluable. The response rate was 20% (95% CI: 9-31%), with 9 subjects achieving PR. The median time to response was 3 months (range 2-11), the median response duration being 3 months (range 3+-12+). After a median follow-up period of 8 months (range 7-16), only 3 of the patients achieving PR are still on treatment. No increased toxicity or potentially detrimental endocrine effects were observed and all of the patients showed good compliance to treatment. Although the loading-dose schedule used in the present series proved to be feasible, it does not appear to provide any clinical advantage over standard-dose MA treatment. 相似文献
172.
Colleoni M Liessi G Mastrapasqua G Boni L Nelli P Vicario G Sgarbossa G Pancheri F Manente P 《Oncology reports》1997,4(5):1025-1028
The prognosis of unresectable hepatocellular carcinoma is poor. Encouraging response rates have been reported with chemoembolization, but no survival advantage has been demonstrated. Assessment of the impact of the treatment modality on prognosis is complicated by a poor understanding of the prognostic factors in the disease. We therefore evaluated, through univariate and multivariate analysis, the role on prognosis of 16 variables in 63 patients submitted to chemoembolization. Patients were treated with epirubicin (50 mg) plus ethiodized oil and gelatin sponge (22 cases) or with a new program combining i.a, chemotherapy with chemoembolization (41 cases) as follows: L-leucovorin, 100 mg/m(2) i.v.; fluorouracil, 800 mg/m(2) i.a.; carboplatin, 250 mg/m(2) i.a. Chemoembolization with mitoxantrone, 10 mg/m(2), plus ethiodized oil and gelatine sponge was performed immediately after. Median survival for the whole group of patients was 294 days. A multivariate analysis showed a highly significant influence on survival for Child's status (p=0.002) and for TNM stage (p=0.01). Median survival for patients with Child's A disease was 13.9 months and for patients with TNM stage I-II disease 19 months. In conclusion, our data suggest that patients with limited disease and adequate liver function have a longer survival after chemoembolization. 相似文献
173.
Gonzalo Pin Arboledas Víctor Soto Insuga María José Jurado Luque Cleofe Fernandez Gomariz Inés Hidalgo Vicario Amalia Lluch Rosello Pedro José Rodríguez Hernández Juan Antonio Madrid 《Anales de pediatría (Barcelona, Spain : 2003)》2017,86(3):165.e1-165.e11
Insomnia is very common during childhood (30% of children under 5), and causes a serious cognitive and emotional consequence in learning, as well as significant medical comorbidity. It also affects the quality of life, not only of the child, but also of the whole family. Paediatrician training in its diagnosis and treatment is usually poor. For this reason a consensus document is presented on the management of insomnia in children and adolescents. This has been developed by members of the Spanish Paediatrics Association, the Spanish Sleep Society, the Spanish Society of Paediatric Outpatient and Primary Care, the Spanish Adolescent Medicine Society, the Spanish Child and Adolescent Society, and the Spanish Paediatric Neurology Society. The group suggests that diagnosis must be clinical and complementary tests will only be required in doubtful cases or when a differential diagnosis is needed. Likewise, treatment should be mainly based on cognitive-behavioural therapy and the modification of sleeping habits. Using medicines and other substances to make the sleep easier is currently quite common, even although there are no clinical guidelines to support this. 相似文献
174.
Abstracts
Echo/Doppler assessment of morphologic and functional abnormalities in restrictive and infiltrative cardiomyopathy 相似文献175.
176.
177.
Antonio J. Melndez-Martínez Isabel M. Vicario Francisco J. Heredia 《Journal of food composition and analysis》2009,22(4):295-302
The influence of externally added ascorbic acid (AA) on the deterioration of carotenoid pattern and colour of orange juices has been assessed. Regardless of the enrichment of the samples with ascorbic acid, the changes in their carotenoid profile were analogous and involved mainly the epoxycarotenoids. The decreases in the levels of the two major carotenoids, namely (9Z)-violaxanthin and (9Z)- or (9′Z)-antheraxanthin, due to acid-elicited 5,6-epoxide to 5,8-furanoxide isomerizations, were markedly distinct, with the levels of the former dropping more markedly. It was observed, in any event, that the decreases were higher in the sample spiked with the higher amount of ascorbic. In view of these results it has been hypothesized that the location of (9Z)-violaxanthin in orange cloud particles could be more accessible to the juice acids to that of (9Z)- or (9′Z)-antheraxanthin. In addition, the enrichment of the juices seems to promote the contact of the carotenoids and the acids during their deterioration. In terms of colour, it has been concluded that these changes in the carotenoids led to colour differences that can be discerned visually and that the use of a black background for the measurements yielded a better differentiation among the samples. 相似文献
178.
Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan 总被引:2,自引:0,他引:2
BACKGROUND: The prevalence of hepatitis G virus (HGV) and its strain variant, the GB agent (GBV-C) is high in non-virus-inactivated plasma products, but, persistent infection in recipients is relatively low. STUDY DESIGN AND METHODS: Stored samples from transfusion donors and recipients in a prospective study of posttransfusion hepatitis were tested for HGV RNA and antibody to the E2 protein (anti-E2). RESULTS: Thirty-two (2.1%) of the 1500 qualified donors were positive for HGV RNA. Twenty-four persons had received a transfusion of blood from one of these 32 viremic donors. Of these 24 recipients, 3 were positive for HGV RNA before transfusion. Of the remaining 21 recipients, 8 became viremic after transfusion, while the other 13 were not infected. Four of the eight infected recipients were persistently positive for HGV RNA, while four became negative in 1 to 3 years. Three of the four patients with HGV clearance seroconverted to anti-E2 positivity. Comparison of the viral titer, viral sequences at E2, storage period of blood donations, and clinical data in the infected and noninfected recipients revealed no significant differences. However, the noninfected recipients seemed to have a higher prevalence of anti-E2 before transfusion. CONCLUSION: The prevalence of HGV viremia in volunteer blood donors in Taiwan is 2.1 percent, and blood from 0.6 percent of them actually causes HGV infection in the recipients. In half of infected recipients, clearance of HGV occurs. Anti-E2 appears in most recipients whose viremia is cleared. 相似文献
179.
Snyder DS; Chao NJ; Amylon MD; Taguchi J; Long GD; Negrin RS; Nademanee AP; O'Donnell MR; Schmidt GM; Stein AS 《Blood》1993,82(9):2920-2928
Ninety-nine consecutive patients with acute leukemia in first complete remission under age 50 (median age 27 years; age range 1 to 47 years) with a histocompatible sibling donor were treated with fractionated total body irradiation (1,320 cGy) and high-dose etoposide (60 mg/kg) followed by allogeneic bone marrow transplantation. Sixty-one patients were diagnosed with acute myelogenous leukemia (AML), 34 patients with acute lymphoblastic leukemia (ALL), 3 patients with biphenotypic acute leukemia, and 1 patient with acute undifferentiated leukemia. Thirty of the 34 patients with ALL had at least one of the following high-risk factors: age greater than 30, white blood cell count at presentation > 25,000/microL, extramedullary disease, certain chromosomal translocations, or the need for greater than 4 weeks of induction chemotherapy to achieve first complete remission. Cumulative probabilities of disease-free survival and relapse at 3 years were 61% and 12%, respectively, for the 61 patients with AML and 64% and 12%, respectively, for the 34 patients with ALL. By stepwise Cox regression analysis, significant prognostic variables for patients with acute myelogenous leukemia were the presence of acute graft-versus-host disease and increasing age, whereas for patients with acute lymphoblastic leukemia, significant variables were age and the development of cytomegalovirus-associated interstitial pneumonia. Complications related to graft-versus-host disease and relapse of leukemia were the major causes of death. 相似文献
180.
Mercedes Gasior Cristina Ferreras Raquel de Paz David Bueno Yasmina Mozo Luisa Sisinni Juan Torres Canizales Berta González Raquel Olivas-Mazón Antonio Marcos Ana Belén Romero Aída Constanzo Isabel Mirones Alba Fernández-Arroyo Antonio Balas Jose Luis Vicario Adela Escudero Víctor Jiménez Yuste Antonio Pérez-Martínez 《Transfusion》2021,61(5):1505-1517